Bellerophon Therapeutics Inc BLPH:OTCPK

*Data is delayed | Exchange | USD
Last | 04/26/24 EDT
0.0554quote price arrow up+0.0004 (+0.7273%)
Volume
17,511
52 week range
0.03 - 11.15
Loading...
  • Open0.0551
  • Day High0.06
  • Day Low0.0551
  • Prev Close0.055
  • 52 Week High11.15
  • 52 Week High Date05/17/23
  • 52 Week Low0.03
  • 52 Week Low Date11/17/23

Key Stats

  • Market Cap677,688.777
  • Shares Out12.23M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change49.73

KEY STATS

  • Open0.0551
  • Day High0.06
  • Day Low0.0551
  • Prev Close0.055
  • 52 Week High11.15
  • 52 Week High Date05/17/23
  • 52 Week Low0.03
  • 52 Week Low Date11/17/23
  • Market Cap677,688.777
  • Shares Out12.23M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • YTD % Change49.73

RATIOS/PROFITABILITY

  • EPS (TTM)-0.84
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)-0.06
  • EBITDA (TTM)-11.029M
  • ROE (TTM)-165.96%
  • Revenue (TTM)5.64M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-164.06%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bellerophon Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company’s focus is to develop its nitric oxide therapy for patients with pulmonary hypertension (PH) using its delivery system, INOpulse. The Company’s INOpulse program is an extension of the technology used in hospitals to deliver continuous flow inhaled nitric...
Naseem Amin M.D.
Independent Chairman of the Board
Craig Jalbert
President, Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Treasurer, Company Secretary, Director
Bobae Kim
Vice President - Regulatory Affairs and Quality Assurance
Address
184 Liberty Corner Road, Suite 302
Warren, NJ
07059
United States

Top Peers

SYMBOLLASTCHG%CHG
ATHXQ
Athersys Inc
0.0044UNCHUNCH
KA
Kineta Inc
0.61-0.0298-4.6577%
PULM
Pulmatrix Inc
2.01-0.07-3.37%
PSTV
Plus Therapeutics Inc
1.69+0.02+1.50%
STAB
Statera Biopharma Inc
0.0007UNCHUNCH